William Rowe
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 4
- HIV/AIDS Research and Interventions 4
- Virology 5
- HIV Research and Treatment 5
- Co-authors
- Jim Zheng (4 shared papers)Scott D. Schroeder (4 shared papers)Stephen R. Yant (3 shared papers)Kelly Wang (3 shared papers)Winston C. Tse (4 shared papers)Raju Subramanian (5 shared papers)Scott A. Wolckenhauer (2 shared papers)Martin S. Rhee (2 shared papers)
- Journals
- CrystEngComm (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Molecular Pharmaceutics (1 paper)Journal of Clinical Investigation (1 paper)The FASEB Journal (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
William Rowe
8 papers receiving 66 citations
Peers
Comparison fields: 5 of 34
- Virology 45
- Infectious Diseases 46
- Spectroscopy 6
- Pharmacology 3
- Biochemistry 2
Countries citing papers authored by William Rowe
This map shows the geographic impact of William Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Rowe more than expected).
Fields of papers citing papers by William Rowe
This network shows the impact of papers produced by William Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Rowe. The network helps show where William Rowe may publish in the future.
Co-authors
The 25 scholars most cited alongside William Rowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 27 | |
| 2 | 2018 | 12 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 8 | |
| 5 | 2024 | 6 | |
| 6 | 1982 | 3 | |
| 7 | 2012 | 2 | |
| 8 | 2021 | 1 |
About William Rowe
William Rowe is a scholar working on Infectious Diseases, Virology, Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 67 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers), HIV/AIDS Research and Interventions (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper), Molecular spectroscopy and chirality (1 paper), Cystic Fibrosis Research Advances (1 paper), Hepatitis C virus research (1 paper) and HIV-related health complications and treatments (1 paper). The work is most often cited by research in Virology (45 citations), Infectious Diseases (46 citations), Spectroscopy (6 citations), Pharmacology (3 citations) and Biochemistry (2 citations). William Rowe has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Jim Zheng, Scott D. Schroeder, Stephen R. Yant, Kelly Wang, Winston C. Tse, Raju Subramanian, Scott A. Wolckenhauer, Martin S. Rhee, Anna Chiu and George Stepan. Their work appears in journals such as CrystEngComm, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmaceutics, Journal of Clinical Investigation and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.